| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11605-010-1173-3 |
| P698 | PubMed publication ID | 20224984 |
| P2093 | author name string | Kaori Ito | |
| Edward E Whang | |||
| Hiromichi Ito | |||
| Michael Abramson | |||
| Daniel T Ruan | |||
| Edward Swanson | |||
| Richard S Swanson | |||
| Nancy Cho | |||
| P2860 | cites work | Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. | Q34131025 |
| The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification | Q34321928 | ||
| Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. | Q34810946 | ||
| TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. | Q35837124 | ||
| Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? | Q35967362 | ||
| Endocrine tumors of the pancreas | Q36343267 | ||
| Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. | Q36793415 | ||
| Surgery in malignant pancreatic neuroendocrine tumors | Q36806544 | ||
| Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry | Q37229754 | ||
| Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital | Q37249621 | ||
| Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience | Q40249258 | ||
| Surgery to cure the Zollinger-Ellison syndrome | Q41686955 | ||
| Pancreaticoduodenectomy for selected periampullary neuroendocrine tumors: fifty patients | Q44011471 | ||
| Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas | Q44579336 | ||
| Resection of pancreatic neuroendocrine tumors: results of 70 cases | Q46079767 | ||
| Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable? | Q51756943 | ||
| Differences in Survival by Histologic Type of Pancreatic Cancer | Q56743587 | ||
| Endocrine pancreatic tumors: factors correlated with survival | Q56999197 | ||
| Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas | Q57767637 | ||
| Determining Prognosis in Patients With Pancreatic Endocrine Neoplasms: Can the WHO Classification System Be Simplified? | Q57846032 | ||
| Islet cell carcinoma of the pancreas | Q71184122 | ||
| Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients | Q77348249 | ||
| Cytoreduction results in high perioperative mortality and decreased survival in patients undergoing pancreatectomy for neuroendocrine tumors of the pancreas | Q79439087 | ||
| Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients | Q80980757 | ||
| Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors | Q81370373 | ||
| P433 | issue | 5 | |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 891-898 | |
| P577 | publication date | 2010-03-12 | |
| P1433 | published in | Journal of Gastrointestinal Surgery | Q15764393 |
| P1476 | title | Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience | |
| P478 | volume | 14 |
| Q37482586 | Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior |
| Q36701636 | Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors |
| Q87563969 | Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications for surgical resection |
| Q35619098 | Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification |
| Q42674511 | One Hundred Thirty Resections for Pancreatic Neuroendocrine Tumor: Evaluating the Impact of Minimally Invasive and Parenchyma-Sparing Techniques |
| Q38703694 | Outcomes of 101 Consecutive Surgical Resections of Gastroenteropancreatic Neuroendocrine Tumours (GEPNETs) at Tata Memorial Hospital: a Referral Bias for Nonfunctional Duodenopancreatic Tumours and the Need for Greater Awareness of GEPNETs as a Dist |
| Q39159369 | Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection. |
| Q36558853 | Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review |
| Q33743715 | Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study |
| Q40551079 | Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas |
| Q51041052 | Prognostic factors and survival in patients with neuroendocrine tumors of the pancreas. |
| Q33597784 | Prognostic factors of long-term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12-year experience from a single center |
| Q36395571 | Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors |
| Q89565996 | Role of Lymph Node Resection and Histopathological Evaluation in Accurate Staging of Nonfunctional Pancreatic Neuroendocrine Tumors: How Many Are Enough? |
| Q57820051 | Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases |
| Q55192213 | Surgical treatment of sporadic pancreatic neuroendocrine tumors: a state of the art review. |
| Q36359089 | Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems |
Search more.